Format

Send to

Choose Destination
Nouv Rev Fr Hematol. 1993 Feb;35(1):13-4.

2-Chlorodeoxyadenosine in haematological malignancies.

Author information

1
Service d'Hématologie Adulte, Hôpital Saint-Louis, Paris, France.

Abstract

Hereditary adenosine deaminase deficiency results in failure of the lymphocyte development. This occurs because of the accumulation of deoxyadenosine nucleotides. 2-chlorodeoxyadenosine (2CdA) resists the action of adenosine deaminase and accumulates in cells. In doses of 0.1 mg/kg/day given for seven days, 2CdA manifests low toxicity and has been found to be effective in patients with hairy cell leukemia, chronic lymphocytic leukemia, low grade lymphoma and acute myeloid leukemia. 2CdA appears like a very promising drug in these indications.

PMID:
8099730
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center